DACS
MRK icon

Dymon Asia Capital (Singapore)’s Merck MRK Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,400
Closed -$379K – 122
2022
Q3 		$379K Hold
4,400
– – 0.09% 89
2022
Q2 		$401K Buy
+4,400
New +$390K 0.03% 102

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s MRK Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) increased its Merck (MRK) stake by 212% in Q2 2026, buying an estimated $2.48M and bringing the position to 31,173 shares worth $4.01M. The position accounts for 0.17% of the portfolio, ranked #85.

Dymon Asia Capital (Singapore) first reported a position in MRK in Q1 2024 and has held it in 5 quarters since. 2,540 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Dymon Asia Capital (Singapore) held 31,173 shares of Merck worth $4.01M as of Q2 2026.
  • Dymon Asia Capital (Singapore) bought 21,173 Merck shares in Q2 2026, an estimated $2.48M.
  • Merck made up 0.17% of Dymon Asia Capital (Singapore)'s portfolio in Q2 2026, its #85 holding.
  • Dymon Asia Capital (Singapore) first reported a position in Merck in Q1 2024 and has held it in 5 quarters since.
  • 2,540 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.